Literature DB >> 31504652

Efficacy of Active Immunization With Attenuated α-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.

Vuvi G Tran1, Arundhathi Venkatasubramaniam2, Rajan P Adhikari2, Subramaniam Krishnan2, Xing Wang1, Vien T M Le1, Hoan N Le1, Trang T T Vu1, Erika Schneider-Smith1, M Javad Aman2, Binh An Diep1.   

Abstract

Staphylococcus aureus is a common pathogen causing infections in humans with various degrees of severity, with pneumonia being one of the most severe infections. In as much as staphylococcal pneumonia is a disease driven in large part by α-hemolysin (Hla) and Panton-Valentine leukocidin (PVL), we evaluated whether active immunization with attenuated forms of Hla (HlaH35L/H48L) alone, PVL components (LukS-PVT28F/K97A/S209A and LukF-PVK102A) alone, or combination of all 3 toxoids could prevent lethal challenge in a rabbit model of necrotizing pneumonia caused by the USA300 community-associated methicillin-resistant S. aureus (MRSA). Rabbits vaccinated with Hla toxoid alone or PVL components alone were only partially protected against lethal pneumonia, whereas those vaccinated with all 3 toxoids had 100% protection against lethality. Vaccine-mediated protection correlated with induction of polyclonal antibody response that neutralized not only α-hemolysin and PVL, but also other related toxins, produced by USA300 and other epidemic MRSA clones.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  MRSA; PVL; antibodies; pneumonia; vaccine; α-toxin

Mesh:

Substances:

Year:  2020        PMID: 31504652      PMCID: PMC6936001          DOI: 10.1093/infdis/jiz437

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  46 in total

Review 1.  Staphylococcus aureus toxins.

Authors:  Michael Otto
Journal:  Curr Opin Microbiol       Date:  2013-12-10       Impact factor: 7.934

2.  Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial.

Authors:  Vance G Fowler; Keith B Allen; Edson D Moreira; Moustafa Moustafa; Frank Isgro; Helen W Boucher; G Ralph Corey; Yehuda Carmeli; Robert Betts; Jonathan S Hartzel; Ivan S F Chan; Tessie B McNeely; Nicholas A Kartsonis; Dalya Guris; Matthew T Onorato; Steven S Smugar; Mark J DiNubile; Ajoke Sobanjo-ter Meulen
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

3.  Targeting Alpha Toxin To Mitigate Its Lethal Toxicity in Ferret and Rabbit Models of Staphylococcus aureus Necrotizing Pneumonia.

Authors:  Binh An Diep; Jamese J Hilliard; Vien T M Le; Christine Tkaczyk; Hoan N Le; Vuvi G Tran; Renee L Rao; Etyene Castro Dip; Eliane P Pereira-Franchi; Paulyn Cha; Scott Jacobson; Rosemary Broome; Lily I Cheng; William Weiss; Laszlo Prokai; Vien Nguyen; C Ken Stover; Bret R Sellman
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 4.  Panton-Valentine leukocidin in the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Wen-Tsung Lo; Chih-Chien Wang
Journal:  Pediatr Neonatol       Date:  2011-03-21       Impact factor: 2.083

5.  Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model.

Authors:  B E Menzies; D S Kernodle
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

6.  Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia.

Authors:  Brook E Ragle; Juliane Bubeck Wardenburg
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

Review 7.  Staphylococcus aureus α-toxin: nearly a century of intrigue.

Authors:  Bryan J Berube; Juliane Bubeck Wardenburg
Journal:  Toxins (Basel)       Date:  2013-06       Impact factor: 4.546

8.  Vaccine protection against Staphylococcus aureus pneumonia.

Authors:  Juliane Bubeck Wardenburg; Olaf Schneewind
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

9.  Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs.

Authors:  Rajan P Adhikari; Thomas Kort; Sergey Shulenin; Tulasikumari Kanipakala; Nader Ganjbaksh; Mary-Claire Roghmann; Frederick W Holtsberg; M Javad Aman
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 10.  Igniting the fire: Staphylococcus aureus virulence factors in the pathogenesis of sepsis.

Authors:  Michael E Powers; Juliane Bubeck Wardenburg
Journal:  PLoS Pathog       Date:  2014-02-13       Impact factor: 6.823

View more
  13 in total

1.  Biochanin A as an α-hemolysin inhibitor for combating methicillin-resistant Staphylococcus aureus infection.

Authors:  Jiaxuan Feng; Dazhong Sun; Li Wang; Xueting Li; Jiyu Guan; Lin Wei; Donghui Yue; Xingye Wang; Yicheng Zhao; Haimiao Yang; Wu Song; Bingmei Wang
Journal:  World J Microbiol Biotechnol       Date:  2021-11-27       Impact factor: 3.312

Review 2.  Staphylococcus aureus infections in children.

Authors:  James E Cassat; Isaac Thomsen
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.968

3.  Vaccination with VLPs Presenting a Linear Neutralizing Domain of S. aureus Hla Elicits Protective Immunity.

Authors:  Jason A Joyner; Seth M Daly; Julianne Peabody; Kathleen D Triplett; Srijana Pokhrel; Bradley O Elmore; Diane Adebanjo; David S Peabody; Bryce Chackerian; Pamela R Hall
Journal:  Toxins (Basel)       Date:  2020-07-11       Impact factor: 4.546

Review 4.  Studying Staphylococcal Leukocidins: A Challenging Endeavor.

Authors:  Angelino T Tromp; Jos A G van Strijp
Journal:  Front Microbiol       Date:  2020-04-15       Impact factor: 5.640

5.  IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus.

Authors:  Hatice Karauzum; Arundhathi Venkatasubramaniam; Rajan P Adhikari; Tom Kort; Frederick W Holtsberg; Ipsita Mukherjee; Mark Mednikov; Roger Ortines; Nhu T Q Nguyen; Thien M N Doan; Binh An Diep; Jean C Lee; M Javad Aman
Journal:  Front Immunol       Date:  2021-03-10       Impact factor: 7.561

6.  Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques.

Authors:  Arundhathi Venkatasubramaniam; Grant Liao; Eunice Cho; Rajan P Adhikari; Tom Kort; Frederick W Holtsberg; Karen E Elsass; Dean J Kobs; Thomas L Rudge; Keith D Kauffman; Nickiana E Lora; Daniel L Barber; M Javad Aman; Hatice Karauzum
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

7.  Proteomics Investigations of Potential Protein Biomarkers in Sera of Rabbits Infected With Schistosoma japonicum.

Authors:  Nian-Nian Bi; Song Zhao; Jian-Feng Zhang; Ying Cheng; Chen-Yang Zuo; Gang-Long Yang; Kun Yang
Journal:  Front Cell Infect Microbiol       Date:  2021-12-22       Impact factor: 5.293

Review 8.  Staphylococcus aureus, Antibiotic Resistance, and the Interaction with Human Neutrophils.

Authors:  Viktoria Rungelrath; Frank R DeLeo
Journal:  Antioxid Redox Signal       Date:  2020-06-23       Impact factor: 8.401

9.  Comparative Transcriptomic Analysis of Staphylococcus aureus Associated with Periprosthetic Joint Infection under in Vivo and in Vitro Conditions.

Authors:  Thao Le Masters; Stephen Johnson; Patricio R Jeraldo; Kerryl E Greenwood-Quaintance; Scott A Cunningham; Matthew P Abdel; Nicholas Chia; Robin Patel
Journal:  J Mol Diagn       Date:  2021-06-05       Impact factor: 5.341

Review 10.  Exploring Virulence Factors and Alternative Therapies against Staphylococcus aureus Pneumonia.

Authors:  Jelle Vlaeminck; Dina Raafat; Kristin Surmann; Leen Timbermont; Nicole Normann; Bret Sellman; Willem J B van Wamel; Surbhi Malhotra-Kumar
Journal:  Toxins (Basel)       Date:  2020-11-18       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.